Doctors will need NICE’s advice for fair drug rationing, says BMABMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d277 (Published 17 January 2011) Cite this as: BMJ 2011;342:d277
- Adrian O’Dowd
The BMA is keen on a strong role for the drug watchdog the National Institute for Health and Clinical Excellence (NICE) if doctors in England take responsibility for choosing which drugs are available on the NHS.
Doctors have been expressing concerns about unfair rationing of drugs when the new general practice commissioning consortiums take charge of deciding which drugs are to be made available to the NHS—a role currently held by NICE (BMJ 2010;341:c6240, doi:10.1136/bmj.c6240).
Launching a consultation in December last year, the Department of Health proposed that NICE lose its power to turn down new drugs for use on the NHS after evaluating …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial